Promising Progeria Drug Candidate Lonafarnib Approaching New Drug Application
stevepb / Pixabay

Promising Progeria Drug Candidate Lonafarnib Approaching New Drug Application

According to a publication from Pharmaceutical Technology, California-based Eiger Biopharmaceuticals is preparing to submit a New Drug Application (NDA) to the Food and Drug Administration (FDA) for their experimental progeria…

Continue Reading Promising Progeria Drug Candidate Lonafarnib Approaching New Drug Application
Recent Study Discovers Potential Treatment for Tau-Related, Neurodegenerative Diseases
GDJ / Pixabay

Recent Study Discovers Potential Treatment for Tau-Related, Neurodegenerative Diseases

According to a story from Science & Technology Research News, at team of researchers led by Kenneth S. Kosik, who is affiliated with UC Santa Barbara, have made a discovery…

Continue Reading Recent Study Discovers Potential Treatment for Tau-Related, Neurodegenerative Diseases
Eiger and the FDA Have Met to Disucss Lonafarnib, an Investigational Treatment For Progeria
jniittymaa0 / Pixabay

Eiger and the FDA Have Met to Disucss Lonafarnib, an Investigational Treatment For Progeria

The US Food and Drug Administration and Eiger BioPharmaceuticals, Inc. have met to discuss lonafarnib, a drug being investigated as a potential treatment for Hutchinson-Gilford Progeria Syndrome. For more detailed…

Continue Reading Eiger and the FDA Have Met to Disucss Lonafarnib, an Investigational Treatment For Progeria
The Discovery Of Blood Protein Biomarkers Will Help Monitor Treatment Response In Progeria
jarmoluk / Pixabay

The Discovery Of Blood Protein Biomarkers Will Help Monitor Treatment Response In Progeria

According to a story from EurekAlert, a recent study published in the journal Pediatric Research reveals new protein biomarkers that researchers can use to evaluate how patients with progeria have reacted…

Continue Reading The Discovery Of Blood Protein Biomarkers Will Help Monitor Treatment Response In Progeria
The Progeria Research Foundation is Working Harder Than Ever
Source: https://pixabay.com/en/people-scientist-microscope-white-219985/

The Progeria Research Foundation is Working Harder Than Ever

Earlier last month, the second clinical trial for progeria was announced as completed. The trial was again funded by The Progeria Research Foundation, spearheaded by Drs. Scott Berns and Leslie…

Continue Reading The Progeria Research Foundation is Working Harder Than Ever
Close Menu